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Abstract
In this work we propose and investigate a new strategy of vaccination, which we call “dynamic
vaccination”. In our model, susceptible people become aware that one or more of their contacts
are infected, and thereby get vaccinated with probability ω, before having physical contact with
any infected patient. Then, the non-vaccinated individuals will be infected with probability β.
We apply the strategy to the SIR epidemic model in a multiplex network composed by two
networks, where a fraction q of the nodes acts in both networks. We map this model of dynamic
vaccination into bond percolation model, and use the generating functions framework to predict
theoretically the behavior of the relevant magnitudes of the system at the steady state. We find a
perfect agreement between the solutions of the theoretical equations and the results of stochastic
simulations. In addition, we find an interesting phase diagram in the plane β − ω, which is
composed by an epidemic and a non-epidemic phases, separated by a critical threshold line βc,
which depends on q. As q decreases, βc increases, i.e., as the overlap decreases, the system is
more disconnected, therefore more virulent diseases are needed to spread epidemics. Surprisingly
we find that, for all values of q, a region in the diagram where the vaccination is so efficient that,
regardless of the virulence of the disease, it never becomes an epidemic. We compare our strategy
with random immunization and find that using the same amount of vaccines for both scenarios,
we obtain that the spread of the disease is much lower in the case of dynamic vaccination when
compared to random immunization. Furthermore, we also compare our strategy with targeted
immunization and we find that, depending on ω, dynamic vaccination will perform significantly
better, and in some cases will stop the disease before it becomes an epidemic.
∗ lgalvere@mdp.edu.ar
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I. INTRODUCTION
In 2009, the pandemic virus (H1N1) was identified as the cause of many cases of human
illnesses in California and Texas and a severe outbreak in Mexico [1–3]. The pandemic
had a reproduction value of approximately 1.5 and appeared to exhibit a community
transmissibility similar to the respiratory pathogen SARS coronavirus (SARS-CoV) [4–
6]. Even though the most commonly affected age group was 5-45 years old, the influenza
also affected other age groups, such as older adults, pregnant women and children. By the
end of the pandemic in 2010, it was registered that the virus caused the death of around
twenty thousand people all over the world, and it was fueled by the mobility between
regions and different countries. In [7] the authors studied the role of travel restrictions in
halting pandemics by using short-range mobility data, and explored alternative scenarios
by assessing the potential impact of mobility restrictions. However, although this strategy
could be very effective, it was found only useful to slow down the spread of the diseases,
which might give time to the health authorities to develop a better strategy to stop the
epidemic, for example the development of a new vaccine. Fortunately, in the case of the
H1N1 pandemic, it was possible to develop and deploy a vaccination campaign, just in
time to prevent a further spreading of the disease.
It is well known that infectious diseases usually spread by physical contact between
individuals in a society [8, 9]. Over the years, researchers have found that the best way
to model these types of contact patterns [10–12] is by using the topology of complex net-
works [13–17], where people are represented by nodes, and their interactions, as links. A
commonly-used model for reproducing the dynamics of the spreading of endemic diseases,
such as seasonal influenza or SARS [6], is the susceptible-infected-recovered (SIR) model
[18–20]. This model groups individuals of a population into three compartments accord-
ing to their state: susceptible (S), infected (I), and recovered (R). When a susceptible
individual is in contact with an infected one, it becomes infected with probability β, which
is the same for everyone. Infected individuals recover after a period of time tr, i.e., they
become immunized and cannot be infected again or infect others. When the parameters
β and tr are constant, the effective probability of infection is given by the transmissibil-
ity T = 1 − (1 − β)tr [21, 22]. The SIR model has a tree-like structure with branches
of infection that develop and expand, and this is because infected individuals cannot be
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re-infected, so the infection can only move forwards. It has been proven that this process
can be mapped into link percolation [23, 24], and thus the dynamic can be described us-
ing the generating function framework. The most important property in this framework
is the probability f that a branch of infection will expand throughout the network [24].
When a branch of infection reaches a node with k connections across one of its links, it
can only expand through its k−1 remaining connections. It can be shown that f satisfies
the transcendental equation f = 1−G1(1−Tf), where G1(x) =
∑kmax
k=kmin
kP (k)/〈k〉xk−1,
for x ∈ [0, 1], is the generating function of the underlying branching process [23]. Note
that G1(1 − Tf) represents the probability that the branches of infection do not expand
throughout the network. In the steady state of this process, there is a critical thresh-
old Tc that separates an epidemic phase from a non-epidemic phase. When T ≤ Tc
there is an epidemic-free phase with only small outbreaks, which corresponds to finite
clusters in link percolation theory. But, when T > Tc an epidemic phase develops, the
branches of infection contribute to a spanning cluster of recovered individuals. Thus, the
probability of selecting a random node that belongs to the spanning cluster is given by
R = 1 − G0(1 − Tf), where G0(x) =
∑kmax
k=kmin
P (k)xk is the generating function of the
degree distribution.
The spread of epidemics in networks [25–28] have been the focus of motivation of several
investigations that seek to develop and study different strategies of mitigation for decreas-
ing the impact of diseases on healthy populations [18, 29–33]. On one hand, referring to
non-pharmaceutical strategies, one of the most common and studied is “quarantine”, in
which all individuals of the affected population must remain in isolation for a period of
time. This scenario is difficult to perform, besides it involves a great economic loss. On
the other hand, a more moderate strategy proposed is “social distancing” [34–36]. In this
strategy, susceptible individuals distance themselves from infected or from those having
the symptoms of the disease, by removing links to them. Although all these strategies are
beneficial, without any doubt, the most effective one is “vaccination” [37] (and references
therein). In the early times random vaccination has been studied [38]. In this protocol
susceptible individuals are vaccinated regardless of whether there are or not in contact
with an infected individual, which requires a huge amount of vaccines and resources that
may not be available. One way to improve this strategy is targeted vaccination [39], that
is to vaccinate those people that have many connections, and therefore, higher probability
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of getting the disease and transmitting it. However, this strategy is difficult to implement,
since the degrees of nodes in the network must be known in detail. In [40], the authors
proposed the acquaintance immunization strategy which does not require knowledge of
degrees. In the model, a fraction of nodes is choosen at random, then some of their clos-
est contacts get immunized. So, given that in scale-free networks a randomly chosen link
points with high probability to a high degree node, this strategy is actually a preferential
immunization of the hubs, which reduces dramatically the amount of vaccines needed to
control the epidemic.
Since the advent of multilayer networks or network of networks these structures have
been the focus of much research and have allowed the scientific community to use a more
realistic approach. With this new insight, the spread of epidemics was once again a thrive
subject to investigate [32, 41–45]. On top of that, the cases of the H1N1 pandemic (2009)
and the Ebola outbreak in Africa (2014), and their catastrophic consequences worldwide,
have prompted the research of new mitigation strategies to avoid similar damages in
future epidemics outbreaks [36, 46–50]. With this motivation in mind, we develop a
vaccination strategy, which we called “dynamic vaccination” on the topology of a multiplex
network. We are interested in studying how epidemic spreads in the presence of this new
protocol of vaccination. In our model, the group of susceptible people that have a relation
with infected individuals, is the target of the immunization strategy. The contacts or
neighbors of an infected person receives a vaccine with a probability ω. If the susceptible
individuals are vaccinated, they acquire immunization and cannot be infected or infect
others anymore.
This strategy, known also in the epidemiology field as “ring vaccination”, has been ap-
plied to eradicate the smallpox [51] and has been studied in [52, 53] due to its efficiency
as a vaccination protocol. It has been also implemented during the Ebola virus epidemic
in West Africa (2015) [54, 55]. In this manuscript we present new insights by applying
the strategy on the SIR epidemic model with the topology of a multiplex network. We
perform stochastic simulations and we apply the generating functions framework to de-
velop theoretical equations that describe the outcome of the model. We find an excellent
agreement between the simulation results and the solutions of the analytical equations.
This manuscript is organized as follows: Section II explains the model and the results
obtained, and this section is divided in three parts A, B and C. In A we present the
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rules of the epidemic model with the dynamic vaccination. Then, in B we develop the
theory that corresponds to the epidemic spreading problem. Lastly, in C we show the
simulations results and compare them with the results of the theoretical equations, which
are solved numerically. Finally, in Section III we present our discussions and outlooks.
II. MODEL AND RESULTS
Our epidemic model is performed on a multiplex system composed of two networks
A and B, each one characterized by a degree distribution P α(k), with α = A,B. Both
networks are connected to each other through a fraction q identical pairs of nodes in both
networks [44]. Those pairs of nodes in network A and B represent the same individual act-
ing in different networks. For example one network could represent the personal contacts
of the individuals at their workplace, and the other network their family or friends.
A. Model
At the initial stage of the Susceptible-Infected-Vaccinated-Recovered model (SI-R/V)
all individuals in both networks are susceptible. We randomly infect an individual in
network A, which we call patient zero, and also its counterpart in network B, in case it
belongs to both networks. Then, all the neighbors of this patient zero (in both networks,
A and B) will be vaccinated and hence immunized with probability ω. For the sake
of simplicity, we consider that this probability is the same for all individuals. On the
other hand, those neighbors who did not get vaccinated will be infected with probability
(1 − ω)β. Once an individual receive a vaccine, it can no longer acquire the disease and
becomes immunized. Infected individuals will recover after tr time steps and can not be
affected by the disease anymore. In Fig. 1 we illustrate the dynamic of our model for
tr = 1 and q = 0.7.
We illustrate the model in Fig. 1. At the beginning of the dynamic, at t = 1, there
is only one infected node (patient zero - in red). In network A, this individual has two
neighbors: one of them gets vaccinated with probability ω, and the other one becomes
infected with probability (1 − ω)β. As both individuals are present in both networks,
their counterparts in network B are also vaccinated and infected, respectively. At t = 2,
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FIG. 1. Schematic of the SI-R/V epidemic process in a multiplex network consisting of
two networks, each of size N = 10. A fraction q of nodes in both networks represent the same
individual acting in different environments. Here q = 0.7. The colors of the nodes represent
the following states: green ( ) for Susceptible (S), red ( ) for Infected (I), blue ( ) for recovered
(R) and black ( ) for vaccinated individuals. In this case, we assume tr = 1. At t = 1, the
patient zero infects one of its neighbors in network A and the other becomes vaccinated. Since
this infected patient is present in both networks, it can also spread the disease in network B.
The red lines indicate the direction of the branches of infection. In the next time step, t = 2,
this patient zero recover in both networks and the new infected individuals continue spreading
the disease. The process continues until the fourth temporary step, which is the steady state,
where there are no more infected individuals that can continue spreading the disease.
patient zero recovers in both networks and the new infected individuals will try to infect
their susceptible neighbors. In network A, one of the new infected individuals has only
one vaccinated neighbor, thus he cannot spread the disease, and the other has three
susceptible neighbors: one gets vaccinated, the other becomes infected, as well as his
counterpart in network B, while the last remains susceptible. In network B there are two
infected individuals, of which only one manages to infect one of its neighbors. At the next
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time step, this infected individual recovers and the newly infected individuals continue
to spread the disease. The dynamic continues until the system reaches a steady state in
which there are no more infected nodes (t = 4) and the epidemic process ends.
B. Theory
In our model of the SI-R/V process we assume that the transmissibility is the same
in both networks, thus, all the individuals in the system spread the infection with the
same probability. As we mentioned earlier, each infected individual in each network can
infect each one of its neighbors (with probability β), if they have not been vaccinated
earlier(with probability (1−ω)). Thus, at each time step the probability that an infected
node infects a susceptible neighbor is (1 − ω)β during a period of time tr, after which
he recovers. Then, the overall transmissibility Tβ ≡ T (β, tr, w) is the probability that an
infected individual will transmit the disease to its neighbors, which is given by,
Tβ = (1− ω)β
tr∑
t=1
[(1− ω)(1− β)]t−1 = 1− (1− ω)
tr(1− β)tr
ω + β − ω β (1− ω) β . (1)
We can use the generating function framework to map this process onto link percolation
in a system of two coupled networks [23, 24], after which we can write two transcendental
coupled equations for fA/B. Thus, the probability of reaching, through a random chosen
edge, a node that belongs to a branch of infection that expands all over the system, is,
fA = (1− q) [1−GA1 (1− TβfA)] + q [1−GA1 (1− TβfA) GB0 (1− TβfB)],
fB = (1− q) [1−GB1 (1− TβfB)] + q [1−GB1 (1− TβfB) GA0 (1− TβfA)]. (2)
Here, G
A/B
0 (x) and G
A/B
1 (x) are the generating functions of the degree and the excess
degree distributions for each network respectively. On one hand, G
A/B
1 (x) represents the
probability that choosing a random edge that leads to a node of degree k in one network,
this branch cannot spread the disease through its remaining k − 1 connections. On the
other hand, G
A/B
0 (x) takes into account the probability that, if the node has a counterpart
node of degree k in the other layer (B/A), the branch of infection does not spread through
its k links, i.e., the branch does not spread in layer B/A.
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In Eqs. (2) the first term in both equations corresponds to those branches of infection
that only spread within their own network, while the second term takes into account those
branches that spread through both networks.
During the dynamics, the branches of infection reaches both recovered and vaccinated
nodes. The difference is that once the infection branch crosses a link to reach a node
that has been vaccinated, this vaccinated individual cannot spread the disease. Thus, we
can develop in the same way as before, a transmissibility Tω ≡ T (β, tr, w) as the effective
probability that a susceptible neighbor in contact with an infected node, for a period of
time tr, will be vaccinated. This transmissibility is given by,
Tω = ω
tr∑
t=1
[(1− ω)(1− β)]t−1 = 1− (1− ω)
tr(1− β)tr
ω + β − ω β ω. (3)
Therefore, in the steady state of our model, the magnitude that maps with the order
parameter of link percolation is not only the fraction of recovered individuals, as in the
standard SIR [18], but instead, it is the sum of vaccinated and recovered, i.e., V + R.
This is due to the fact that the infection branches also reach those nodes that were
vaccinated via a link. A susceptible individual can get vaccinated only if he has an
infected neighbor that could infect him through a S-I link. To consider this event in the
equations, a multiplicative factor must be added, which takes into account the probability
that a susceptible node becomes infected or vaccinated if its state is altered by one of its
infected neighbors.
Then, for the parameter R, we should consider the probability that a randomly chosen
node is connected to a branch of infection through at least one of it’s k links. Thus, the
fraction of recovered individuals in each network can be written as,
RA =
Tβ
Tβ + Tω
{(1− q) [1−GA0 (1− TβfA)] + q [1−GA0 (1− TβfA) GB0 (1− TβfB)]} ,
RB =
Tβ
Tβ + Tω
{(1− q) [1−GB0 (1− TβfB)] + q [1−GB0 (1− TβfB) GA0 (1− TβfA)]} . (4)
And the fraction of vaccinated nodes is given by,
VA =
Tω
Tω + Tβ
{(1− q) [1−GA0 (1− TβfA)] + q [1−GA0 (1− TβfA) GB0 (1− TβfB)]} ,
VB =
Tω
Tω + Tβ
{(1− q) [1−GB0 (1− TβfB)] + q [1−GB0 (1− TβfB) GA0 (1− TβfA)]} . (5)
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Then, the total fraction of recovered (R) and vaccinated (V) individuals in the system is
given by,
R = (RA +RB − ζR)/(2− q)
V = (VA + VB − ζV )/(2− q), (6)
where ζR =
Tβ
Tω+Tβ
q[1 − GA0 (1 − TβfA)GB0 (1 − TβfB)] is the fraction of shared nodes that
are recovered and ζV =
Tω
Tβ+Tω
q[1 −GA0 (1− TβfA)GB0 (1 − TβfB)] is the fraction of shared
nodes that are vaccinated, in the steady state.
From Eqs. (1) and (2) we can see that if we use the total transmissibility, which is
the sum of Tβ and Tω, as the control parameter we lose information about the probability
of vaccination, ω (see Appendix IVA). Hence, we will make use of the virulence of the
diseases β as the control parameter. To this end, we fixed tr = 1 and obtain β by inverting
Eq. (1).
C. Simulation Results
In the simulations, we generate two uncorrelated networks, A and B, of equal size using
the Molloy-Reed algorithm [56]. We randomly overlap a fraction q of nodes in network
A with nodes in network B by a one-to-one connection. The degree distribution in each
network is given by Pi(k), with i = A,B and kmin ≤ k ≤ kmax, where kmin and kmax are the
minimum and the maximum degree that a node can have. We assume that an epidemic
takes place in a single realization if the number of recovered individuals is larger than a
certain value sc. Since we consider networks of size N = 10
5 we chose sc = 200 [57, 58].
To calculate the total number of recovered and vaccinated nodes throughout the entire
system, the pair of nodes that act in both networks are counted as single nodes. For the
sake of simplicity we set tr = 1.
In Fig. 2 we show the total number of recovered (R) and vaccinated (V) nodes as a
function of β for two different vaccination scenarios, and we vary the overlap q between
the layers. To see the effect of the multilayer structure we consider two different networks:
layer A is an Erdős-Rényi (ER) network [59], with average degree 〈kA〉 = 4, kmin = 0
and kmax = 40. Nodes with a connectivity equal to kA = 0 are isolated in layer A
and can only be infected in layer B. Thus, this nodes do not play a major role in the
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spreading process between layers. The layer B is a truncated scale free network (SF)
where PB(ki) ∼ k−λBi e−ki/c with λB = 2.5, kmin = 2, kmax =
√
105 and an exponential
cutoff c = 50 [23]. Both networks are with N = 105 nodes. Each curve corresponds to
a different value of ω = 0, 0.1, 0.3, 0.5, 0.7, 0.8 from left to right. We consider the cases
q = 0.1 ((a) and (b)), and q = 0.9 ((c) and (d)). Insets in Fig. 2 (b) and 2(d) correspond to
the maximum in the fraction of vaccinated individuals Vpeak, if there is one, as a function
of ω.
Figure 2 shows excellent agreement between simulation results and the theoretical
analysis (Eqs. (4) and(6)). As expected, the critical threshold βc increases as q decreases.
Hence, for less interconnected networks a more virulent disease is needed in order to
become an epidemic. For instance, for ω = 0.8 there is a noticeable difference in βc, when
q is low the reach of the disease is insignificant while for q closed to one reaches 10% of
the healthy population. On top of that, it can be seen that qualitatively, the behaviors
of both magnitudes, are very similar regardless the overlap.
In Fig. 2(a) and 2(c) we can see that as ω increases the total fraction of recovered
nodes decreases. For high values of β, such as β = 1, when ω = 0.1 the disease reaches
90% of the population, regardless of the overlap. But as ω increases, the immunized
individuals block many of the paths that would be used by the disease to spread through
the population. This causes a decrease in the probability that the disease might spread
or “percolate” through an edge. Thus, as the probability of vaccination gets higher, the
disease has to be more virulent to reach the entire system, which translates into an increase
in the critical infection threshold βc. Notice that for ω & 0.8, the disease never originates
an epidemic despite its virulence.
In contrast, in Fig. 2(b) and 2(d), we can see that the total fraction of vaccinated
nodes does not behave monotonically with β. For small β, V increases until it reaches
a maximum value, then starts to decrease. This maximum value varies with ω, is more
pronounced for low values of ω and vanishes as ω becomes larger. The inset in each plot
shows this peak as a function of ω. When the probability of vaccination is equal to zero,
there is no vaccinated nodes. However, slightly above ω = 0 a peak exhibits. Then, as
ω increases the fraction of vaccinated individuals in the peak also increases reaching a
certain value of ω above which the peak vanishes. Note that this maximum value also
varies with the overlap fraction, q.
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FIG. 2. Theoretical and Simulation results of the total fraction of recovered (R) and
vaccinated (V) nodes, for two different overlap scenarios (q = 0.1, 0.9), as a function of the
virulence of the diseases β and for different values of ω, in the steady state of the process. We
consider tr = 1, (a)-(b) q = 0.1 and (c)-(d) q = 0.9, and ω = 0, 0.1, 0.3, 0.5, 0.7, 0.8 from left
to right. The symbols correspond to the simulation results and the lines correspond to the
theoretical evaluation of Eqs. (6). The multiplex network consists of two layers, each of size
N = 105. Layer A is a ER network with 〈kA〉 = 4 with kmin = 0 and kmax = 40, and layer B
is a SF network with λB = 2.5, kmin = 2, kmax =
√
105 and exponential cutoff c = 50, thus
〈kB〉 ≃ 3.66. Simulation results are averaged over 104 realizations.
The origin of the peaks is the competition between the spread of the disease and the
vaccination process. For instance, let’s consider the case of low values of ω, such as
ω = 0.1. Slightly above βc, the disease is not virulent enough so, increasing β the number
of infected and vaccinated nodes increases. This is true until a certain value of β, that
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corresponds to the peak in V, above which individuals are more likely to become infected
rather than vaccinated. On the contrary, in the case of high ω values, the peak is not
exhibited. This is due to the fact that the virulence of the disease is not strong enough
to overcome the vaccination. Furthermore, as ω increases and for high values of overlap,
the fraction of vaccinated individuals is much higher than for low values of q.
Now, in order to study the interplay between the layers we vary the overlap in the
system and consider a scenario of low and high probability of vaccination, ω = 0.1 (left)
and ω = 0.7 (right). We show in Fig. 3 the difference between the total number of
recovered individuals (RA - RB) of each layer as a function of β. Each curve corresponds
to different values of q, with q ∈ [0, 1], and ∆q = 0.1. In Fig. 3(a)-(b) we consider in
layer A an ER network with average degree 〈kA〉 = 4, kmin = 0 and kmax = 40, and in
layer B a SF network with λA = λB = 2.5, kmin = 2, kmax =
√
105 and an exponential
cutoff c = 135, thus 〈kB〉 ≃ 4 [23]. Note that this type of SF networks is appropriate
to describe scenarios and structures of real-word systems [60]. For the case of isolated
networks, q = 0, we can observe that there is a notable difference between the fraction of
recovered individuals in each layer. For low values of β it is well known that the level of
the epidemic is higher in layer B due to the ultra small world property [61]. In Fig. 3(a),
when the probability of vaccination is low, there are two regimes: for low values of β,
the disease spreads more in the SF network, but above a certain β value the ER network
topology is more efficient to propagate the infection. In Fig. 3(c), the networks have the
same topology, and thus, it is expected that there will be more recovered individuals in
the network (layer B) with larger average degree.
In Fig. 3(b) we can observe that for ω = 0.7 the vaccination strategy is very effective,
and the difference between the spreading of the disease is low. As we can see from the
inset, this is due to the fact that the disease almost does not spread. Besides, when
q = 0 (solid lines), the critical value above which the epidemic occurs, is different for each
network and much lower for the SF network. But for the case of q = 0.5 (dash-dotted
lines) this value is dominated by the network where the epidemic spreads more easily.
Besides, for β = 1 the infection reaches nearly a 10% of the population, and even more in
the SF network. However, when the networks are overlapped the infection spreads more
easily, and hence as q increases the difference between the RA and RB shrinks to zero.
Focusing on the critical threshold βc, this can be obtained theoretically from the inter-
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FIG. 3. Difference between the fraction of recovered and vaccinated individuals in
both layers as a function of the virulence of the disease for different values of the overlap q.
We consider ω = 0.1(left), 0.7(right) and tr = 1. The overlap q varies from 0 ( ) to 1 ( ) with
∆q = 0.1. The curves correspond to the theoretical evaluation of Eqs. (6). In (a) and (b) we
consider in layer A an ER network with average degree 〈kA〉 = 4, kmin = 0 and kmax = 40, and
in layer B a SF network with λA = λB = 2.5, kmin = 2, kmax =
√
105, and exponential cutoff
c = 135, thus 〈kB〉 ≃ 4. Both networks are of the same size N = 105. In (c)-(d) the system is
composed by two ER, layer A with 〈kA〉 = 4 and layer B with 〈kB〉 = 10, both with kmin = 0
and kmax = 40. The insets show the fraction of recovered individuals in each layer for the case
of q = 0 (solid lines) and q = 0.5 (dash-dotted lines).
section of the two Eqs. (2) where all branches of infection stop spreading, which is given
when fA = fB = 0. This is equivalent to find the solution of the system det(J − I) = 0
where I is the identity matrix and J is the Jacobian matrix of the coupled equation with
Ji,k|fi=fk=0 = ∂fi/∂fk|fi=fk=0. In [44], this theoretical critical value has been obtained for
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standard SIR model in a partially overlapped multiplex networks, T SIRc , and it is equal to
the transmissibility of our model, T SIRc = Tc. However, the critical infection probabilities
are different in both models. For instance, for tr = 1 it is well known that T
SIR
c = β
SIR
c ,
and in our model Tc = βc(1 − ω). Thus βSIRc = βc(1 − ω). Next, to account how the
magnitudes change with ω, we will focus on the critical value of virulence of the diseases,
βc = β
SIR
c /(1 − ω) and not on the critical transmissibility. Using numerical evaluations
we find a physical and stable solution for βc.
In Fig. 4 we display a surface plot that shows how the critical infection probability βc
depends on the vaccination probability ω and the overlapping between layers q. In the
figures at the top, we consider the cases of an ER network in layer A, and a SF network in
layer B. Figures at the bottom correspond to the case of two ER networks. In all figures
we set tr = 1.
From Fig. (4) we can see that the surface, which represents the critical virulence,
separates two phases: one epidemic (regime above the surface) and another epidemic-free
(regime below the surface). We observe that in all cases as q decreases and ω increases
the non-epidemic phase becomes wider. Furthermore, as we increase ω, for all values of q,
we can see the existence of a threshold above which, even for very virulent diseases, the
outbreak will never become an epidemic. The behavior of the plots in Fig. 4 is similar.
From the figures above, we can see that by decreasing λB, we increase the heterogeneity of
the network, and this facilitates the spread of the disease, since once the infection reaches
a hub, a high degree node, it spreads rapidly across the network. The same applies for
figures on the bottom, by connecting two networks with low average degree, the infection
does not propagate so easily.
Finally, in Fig. 5 we theoretically compare our strategy of dynamic vaccination with a
very effective strategy, targeted vaccination [62], and with another that usually performs
poorly, random vaccination [63]. In the case of random vaccination, a random fraction V
of nodes in layer A are vaccinated before the spreading of the disease, and if those nodes
have a counterpart in layer B, they will also get immunization against the infection. On
the other hand, in the targeted immunization strategy, we choose a fraction V of the
highest connected individuals in layer A to get vaccinated.
We consider the case of (a)-(b) two ER multiplex networks with the same average
degree, equal to 〈kA/B〉 = 5, and (c)-(d) two scale free networks where λA = λB = 2.5.
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FIG. 4. Surface phase diagram obtained theoretically for the case of tr = 1. In the top panels
we consider in layer A an ER network with 〈kA〉 = 2 with kmin = 0 and kmax = 40, and in layer
B a SF network with (a) λB = 1.5 and (b) λB = 3.5, kmin = 2, kmax =
√
105 and exponential
cutoff c = 135. On the bottom we consider two ER networks with 〈kA〉 = 2 in layer A and (c)
〈kB〉 = 2 (d) 〈kB〉 = 5 in layer B. In all kmin = 0 and kmax = 40. In all networks, N = 105. We
can see that there are two well marked regions: an epidemic and a non-epidemic phase, separated
by a critical value of β. Increasing the overlapping q facilitates the spread of the epidemic, thus,
βc decreases and the epidemic phase regime is smaller. In all figures there is a critical value of
ω above which, regardless of the virulence of the disease, there is no epidemic. In the case of no
vaccination, ω = 0, we recover the regular SIR in multiplex networks and as ω increases, there
will be more vaccinated individuals so βc increases.
We set tr = 1, β = 0.3, and vary the overlap between networks (a)-(c) q = 0.3 and
(c)-(d) q = 0.7. Fig. 5 shows the total fraction of recovered nodes in the steady state
as a function of V and ω. In Fig.5(a), when the total fraction of vaccinated individuals
is, for instance, V = 0.2, for the case of random vaccination R ≃ 0.55, while targeted
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immunization performs much better, R ≃ 0.15. On the other hand, note that for dynamic
vaccination there are two possible outcomes of R depending on ω. Using the same amount
of vaccines (V = 0.2), if ω ≃ 0.3 then R ≃ 0.4, but for ω ≃ 0.6, we have a much more
interesting scenario where the final fraction of recovered individuals is close R ≃ 0.1. In
this last case, there is almost no difference between targeted and dynamic vaccination. In
some cases, there is a threshold value V ∗, above which there is no epidemic. For instance,
in Fig. 5(b), V ∗ = 0.45 (targeted) and V ∗ = 0.65 (random). However, in the case of
dynamic vaccination V ∗ → 0 when ω → 1, i.e., a very small amount of vaccines is needed
to prevent the epidemic. In short, from Fig. 5 we can see that, for the same amount
of vaccinated individuals, the number of recovered individuals is significantly lower for
dynamic vaccination compared to random vaccination. This is observed in all plots,
which indicates that our strategy is significantly more effective than random vaccination.
Especially, in more heterogeneous networks, such as SF networks, we can see that this
strategy is even more efficient.
On the other hand, if we compare our strategy with targeted vaccination, there is a
certain value of ω above which in dynamic vaccination performs much better, even using
a lower amount of vaccines than in targeted vaccination. Notably, this is also observed
for scale free networks, in which the immunization of the hubs is usually an extremely
effective strategy. This is because when the contacts of an infected node are immunized, is
highly likely that at least one of that contacts is a hub. Thus, for SF networks our strategy
also targets high connectivity nodes, preventing a massive spreading of the disease.
Furthermore, when the system is more interconnected, the disease spreads more.
Therefore, more vaccines are needed to prevented it from becoming an epidemic. For
example, for a final fraction of recovered individuals equal to 20% of the population,
it is required to vaccinate a fraction of individuals equal to V (q = 0.3) ≃ 0.25 and
V (q = 0.7) ≃ 0.4.
To summarize, we demonstrate that, on top of a multiplex network structure, dynamic
vaccination strategy is much more efficient than random immunization. Using the same
amount of vaccines, the total fraction of recovered individuals is always lower in the case
of dynamic vaccination. Besides, in our strategy, depending on the parameters, we obtain
a region where regardless of the virulence of the disease it will never become an epidemic.
In comparison, if we vaccinate the same number of individuals, the fraction recovered
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FIG. 5. Comparison between dynamic, random and targeted vaccination. Theoretical
results of the total fraction of recovered (R) nodes as a function of V. All dotted lines correspond
to random vaccination ( ), the dashed lines to targeted immunization ( ) and the colored
solid lines correspond to our strategy of dynamic vaccination. For the case of dynamic vaccination
the colors in the curves indicate different values of ω. Notice that ω decreases from top to bottom.
We set tr = 1, β = 0.3 and consider different values of overlap (a)-(c) q = 0.3 and (b)-(d) q = 0.7.
In (a)-(b) we used two ER networks with 〈kA〉 = 〈kB〉 = 5 with kmin = 0 and kmax = 40, and
in (c)-(d) two scale free networks, with λA = λB = 2.5, kmin = 2, kmax =
√
N , N = 105 and
exponential cutoff c = 50.
in dynamic immunization will always be below that obtained if we vaccinate at random.
Due to this result, our strategy can be very beneficial to be implemented in real scenarios,
for example in outbreaks of Ebola or influenza, such as H1N1.
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III. DISCUSSION
In summary, we studied a novel model of dynamic vaccination on a system composed
of two partially overlapped networks, where q is the fraction of common nodes in both
networks. In our model, susceptible individuals in contact with infected patients have the
opportunity to be vaccinated before the their neighbors attempt to infect them. That is,
each time an infected person comes in contact with a susceptible individual, this one will
try to get vaccinated with probability ω and if he does not succeed he will be infected with
probability β. Each infected node is assumed to recover after tr time steps and will become
immunized. Besides, vaccinated nodes are also immunized and can not be infected or infect
others. Mapping this process into bond percolation and using the framework of generating
functions, we analyzed analytically the total fraction of recovered and vaccinated nodes in
the steady state as a function of the virulence of the diseases β for different values of the
ω and q, and we found a perfect agreement between the theoretical and the simulation
results. As expected we find that as ω increases the epidemic threshold βc becomes larger,
and disappearing for very large values of ω. We also find a peak, for certain values of the
parameters, in the fraction of vaccinated nodes as a function of ω, which is determined by
the competition between the vaccination strategy and the spread of the disease. We find
an interesting phase diagram in the plane β−ω, where we can see an epidemic phase, which
diminish as q and ω increase, and a non-epidemic phase, where the diseases can not spread.
A remarkable result of the phase diagram is that for certain values of q and ω, regardless
of the virulence of the disease, it will never become an epidemic. Finally, we demonstrate
that our strategy is always more efficient than random immunization and depending on
ω, performs better or worse than targeted vaccination. For high vaccination probabilities,
i.e., when the population is more receptive to be vaccinated, dynamic immunization is
the most effective strategy to avoid or mitigate an epidemic. This goal can be achieved,
using efficiently the available vaccines, immunizing a small fraction of the population and
creating a barrier of vaccinated individuals that the infection can not pass through.
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APPENDIX
A. Dependence on Tβ
In this section we show the dependence on the overall transmissibility Tβ of the recov-
ered and vaccinated fraction of nodes, R and V , in the steady state. Also, we show the
dependence on the prefactors that multiply Eqs. (4) and (5), which measure the relative
weight of the probabilities of infection (or vaccination) in the dynamic.
As we saw earlier in Sec. II B, from Eqs. (1) and (3) we find the prefactors in Eqs. (4)
and (5) as,
Bβ =
Tβ
Tβ + Tω
=
(1− ω) β
(1− ω)β + ω ,
Bω =
Tω
Tβ + Tω
=
ω
(1− ω)β + ω . (7)
Note, interestingly these prefactors are independent of the recovery time tr.
In Fig. 6 we plot in (a) the total fraction of recovered nodes R, (b) R/Bβ, (c) total
fraction of vaccinated nodes V and (d) V/Bω, as a function of the epidemic transmissibility
Tβ for different values of ω, from ω = 0.1 to ω = 0.8, with intervals of ∆ω = 0.1. For
the sake of simplicity we consider the case tr = 1. Thus, from Eq. (1) the epidemic
transmissibility is reduced to Tβ = (1− ω)β.
The multiplex network consists of two coupled Erdős-Rényi (ER) networks with q =
0.3, average degree 〈kA〉 = 〈kB〉 = 5 and, kmin = 0 and kmax = 40.
As we can see, in Fig. 6(a) and (c) for the different ω values, when R and V are plotted
as a function of Tβ all the curves collapse in the same critical threshold, when ω = 0 [62],
which is equal to,
Tβ |(β=βc) =
1
〈k〉 (1 + q) . (8)
Since we consider 〈k〉 = 〈kA〉 = 〈kB〉 = 5 and q = 0.3, then for Fig. 6 the critical
threshold is Tβ |(β=βc) ≃ 0.15.
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FIG. 6. Theoretical Results of the total fraction of (a) recovered R, (b) R/Bβ, (c) vaccinated
V and (d) V/Bω nodes as a function of the overall transmissibility Tβ = (1 − ω) β when tr = 1
and for different values of ω, in the steady state. The multiplex network consists of two ER
networks and we set q = 0.3. Each network size is N = 105 and 〈kA〉 = 〈kB〉 = 5 with kmin = 0
and kmax = 40.
Notice that, for instance, for tr = 1 we have Tβ = β (1 − ω), and thus for a fixed
vaccination probability Tβ ∈ [0, 1− ω], with ω ∈ [0, 1]. Then, Tβ /∈ [0, 1], as the transmis-
sibility in the standard SIR. In Figure 6, as each curve corresponds to a different value
of ω, they will reach maximum values at different Tβ. Furthermore, as ω increases each
curve becomes shorter since the dependency on ω is still present in the prefactors.
In Fig. 6 (b) and (d) we multiply all the curves (fraction of recovered nodes) by the
weighted scaled prefactor of infection, and we can see that all data collapse into a single
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curve. This is due to the fact that with this scaling the dependence on ω is removed.
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